Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)

NCT ID: NCT02943785

Last Updated: 2022-03-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1426 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-21

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

When the upper chambers of a person's heart receive or generate irregular electrical signals, it causes abnormal rhythm in the heartbeat. This is called atrial fibrillation.

Atrial fibrillation goes along with blood clots that may cause mainly strokes and less often other diseases, such as a heart attack. Some patients with atrial fibrillation have other heart disease, such as heart valves that may need to be replaced using catheters.

Often doctors give patients drugs that reduce those blood clots. These are either vitamin K antagonist (VKA) or direct anticoagulants, such as edoxaban. In these patients, it is unclear which of the drugs is better for reducing stroke without increasing severe bleedings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Use of Edoxaban in patients with atrial fibrillation (AF) and indication to chronic oral anticoagulation (OAC) after transcatheter aortic valve implantation (TAVI)

Objective:

* To assess the effect of Edoxaban versus vitamin K antagonist (VKA) on net adverse clinical events (NACE), i.e., the composite of all-cause death, myocardial infarction (MI), ischemic stroke, systemic thromboembolism (SEE), valve thrombosis, and major bleeding (International Society on Thrombosis and Haemostasis \[ISTH\] definition).
* To assess the effect of Edoxaban versus VKA on major bleeding (ISTH definition).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Edoxaban-based Regimen

Edoxaban-based regimen 60 mg and 30 mg film coated tablet for once-daily oral use, and 15 mg film coated tablet in case of transitioning at the end of treatment. Dosing must follow the locally approved label.

Group Type EXPERIMENTAL

Edoxaban-based Regimen

Intervention Type DRUG

15 mg, 30 mg and 60 mg film coated tablet for oral use (with anti-platelet therapy pre-declared at randomization if prescribed)

VKA-based Regimen

VKA-based regimen oral VKA tablets as selected and provided by the site and used in accordance with the local label. The Investigator will monitor the patient and adjust the VKA dose to maintain the dose within target.

Group Type ACTIVE_COMPARATOR

VKA-based Regimen

Intervention Type DRUG

Dosed at International Normalized Ratio (INR) levels, which is a test of how long it takes for blood to clot. Standard of Care treatment in the country location (with anti-platelet therapy pre-declared at randomization if prescribed).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Edoxaban-based Regimen

15 mg, 30 mg and 60 mg film coated tablet for oral use (with anti-platelet therapy pre-declared at randomization if prescribed)

Intervention Type DRUG

VKA-based Regimen

Dosed at International Normalized Ratio (INR) levels, which is a test of how long it takes for blood to clot. Standard of Care treatment in the country location (with anti-platelet therapy pre-declared at randomization if prescribed).

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Savaysa Lixiana

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meets protocol-specified criteria for qualification and contraception
* Is willing and able to comply with any restrictions related food, drink and medications
* Voluntarily consents to participate and provides written informed consent prior to any protocol-specific procedures

Exclusion Criteria

* Has history or current use of over-the-counter medications, dietary supplements, or drugs (including nicotine and alcohol) outside protocol-specified parameters
* Has signs, symptoms or history of any condition that, per protocol or in the opinion of the investigator, might compromise:

1. the safety or well-being of the participant or study staff
2. the safety or well-being of the participant's offspring (such as through pregnancy or breast-feeding)
3. the analysis of results
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chiltern International Inc.

INDUSTRY

Sponsor Role collaborator

Daiichi Sankyo

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Global Clinical Leader

Role: STUDY_DIRECTOR

Daiichi Sankyo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

University of Arizona Sarver Heart Center

Tucson, Arizona, United States

Site Status

Arkansas Site Management Services

Little Rock, Arkansas, United States

Site Status

Loma Linda University Medical Center

Loma Linda, California, United States

Site Status

Cedar-Sinai Heart Institute

Los Angeles, California, United States

Site Status

UCLA Cardiovascular Center

Los Angeles, California, United States

Site Status

University of California - San Francisco

San Francisco, California, United States

Site Status

Santa Barbara Cottage Hospital

Santa Barbara, California, United States

Site Status

Medstar Washington Hospital Center

Washington D.C., District of Columbia, United States

Site Status

Medical Facility Associates

Washington D.C., District of Columbia, United States

Site Status

Cardiology Associate Research

Daytona Beach, Florida, United States

Site Status

International Research Partners, LLC.

Doral, Florida, United States

Site Status

Memorial Healthcare Systems

Hollywood, Florida, United States

Site Status

UF Health Jacksonville

Jacksonville, Florida, United States

Site Status

Watson Clinic Center for Research

Lakeland, Florida, United States

Site Status

Tallahassee Research Institute, Inc.

Tallahassee, Florida, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

Carle Foundation Hospital

Urbana, Illinois, United States

Site Status

St. Vincent Heart Center

Indianapolis, Indiana, United States

Site Status

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Site Status

Maine Medical Center

Scarborough, Maine, United States

Site Status

Washington Adventist Hospital

Takoma Park, Maryland, United States

Site Status

Baystate Health

Springfield, Massachusetts, United States

Site Status

University of Massachusetts Memorial Medical Center

Worcester, Massachusetts, United States

Site Status

Sparrow Clinical Research Institute

Lansing, Michigan, United States

Site Status

MidMichigan Medical Center Midland

Midland, Michigan, United States

Site Status

Michigan Heart, St. Joseph Mercy Health System

Ypsilanti, Michigan, United States

Site Status

Essentia Health

Duluth, Minnesota, United States

Site Status

Mayo Clinic Rochester

Rochester, Minnesota, United States

Site Status

HealthEast Medical Research Institute

Saint Paul, Minnesota, United States

Site Status

Jackson Heart Clinic

Jackson, Mississippi, United States

Site Status

Clinical Investigators LLC

St Louis, Missouri, United States

Site Status

Renown Regional Medical Center

Reno, Nevada, United States

Site Status

Hackensack University Medical Center

Hackensack, New Jersey, United States

Site Status

The Valley Hospital

Paramus, New Jersey, United States

Site Status

New Mexico Heart Institute

Albuquerque, New Mexico, United States

Site Status

NY Presbyterian - Brooklyn Methodist Hospital

Brooklyn, New York, United States

Site Status

St. Francis Hospital

East Hills, New York, United States

Site Status

St. Joseph's Physicians

East Syracuse, New York, United States

Site Status

Rochester General Hospital

Geneva, New York, United States

Site Status

Northshore Community Hospital

Manhasset, New York, United States

Site Status

Mt. Sinai Hospital

New York, New York, United States

Site Status

Stony Brook University Medical Center

Stony Brook, New York, United States

Site Status

Moses H. Cone Memorial Hospital Operating Corporation d/b/a Cone Health

Greensboro, North Carolina, United States

Site Status

East Carolina Heart Institute

Greenville, North Carolina, United States

Site Status

Promedica Toledo Hospital

Toledo, Ohio, United States

Site Status

Oklahoma Heart Hospital Research Foundation

Oklahoma City, Oklahoma, United States

Site Status

Southern Oregon Cardiology

Medford, Oregon, United States

Site Status

Providence Heart and Vascular Institute

Portland, Oregon, United States

Site Status

St. Luke's University Health Network

Bethlehem, Pennsylvania, United States

Site Status

Doylestown Health Cardiothoracic Surgery

Doylestown, Pennsylvania, United States

Site Status

Penn State Health, Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

Site Status

Geisinger Wyoming Valley Medical Center

Wilkes-Barre, Pennsylvania, United States

Site Status

Pinnacle Health

Wormleysburg, Pennsylvania, United States

Site Status

WellSpan York Hospital

York, Pennsylvania, United States

Site Status

Black Hills Cardiovascular Research

Rapid City, South Dakota, United States

Site Status

SCRI - Centennial Medical Center

Nashville, Tennessee, United States

Site Status

Seton Heart Institute

Austin, Texas, United States

Site Status

Houston Methodist Research Institute

Houston, Texas, United States

Site Status

University of Texas Health Science Center Houston

Houston, Texas, United States

Site Status

Legacy Heart Center

Plano, Texas, United States

Site Status

Inova Heart and Vascular Institute

Falls Church, Virginia, United States

Site Status

Virginia Mason Medical Center

Seattle, Washington, United States

Site Status

Providence Sacred Heart Medical Research Center

Spokane, Washington, United States

Site Status

CAMC Memorial Hospital

Charleston, West Virginia, United States

Site Status

Aurora St. Luke's Medical Center

Milwaukee, Wisconsin, United States

Site Status

Medizinische Universitaet Graz

Graz, , Austria

Site Status

Clinic Wels-Grieskirchen GmbH

Grieskirchen, , Austria

Site Status

Universitaetsklinik fuer Innere Medizin III

Innsbruck, , Austria

Site Status

Klinikum Klagenfurt am Worthersee

Klagenfurt, , Austria

Site Status

Wilhelminenspital

Vienna, , Austria

Site Status

Universitätsklinik für Innere Medizin II

Vienna, , Austria

Site Status

Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhugel

Vienna, , Austria

Site Status

ASZ Aalst - Aalst campus

Aalst, , Belgium

Site Status

ZNA - Stuivenberg Ziekenhuis Netwerk Antwerpen

Antwerp, , Belgium

Site Status

Hospital Erasme

Brussels, , Belgium

Site Status

UZA - Universtiair Ziekenhuis Antwerpen

Edegem, , Belgium

Site Status

ZOL Genk, Campus Sint-Jan

Genk, , Belgium

Site Status

Jessa Ziekenhuis- Campus Virga Jessa

Hasselt, , Belgium

Site Status

CHU de Liege

Liège, , Belgium

Site Status

AZ Delta Roeselare

Roeselare, , Belgium

Site Status

University of Alberta Hospital

Edmonton, Alberta, Canada

Site Status

Kingston Health Sciences Centre

Kingston, Ontario, Canada

Site Status

London Health Sciences Centre

London, Ontario, Canada

Site Status

Newmarket Cardiac Surgery Research Incorporated

Newmarket, Ontario, Canada

Site Status

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Site Status

University Health Network

Toronto, Ontario, Canada

Site Status

Montreal Heart Institute

Montreal, Quebec, Canada

Site Status

Hamilton General Hospital

Hamilton, , Canada

Site Status

Universitè Laval

Québec, , Canada

Site Status

Horizon Health Network

Saint John, , Canada

Site Status

CHU d'Angers

Angers, , France

Site Status

Clinique Saint Augustin

Bordeaux, , France

Site Status

Hopital Henri Mondor

Créteil, , France

Site Status

Institut Coeur Poumon - CHRU de Lille

Lille, , France

Site Status

CHU Arnaud de Villeneuve

Montpellier, , France

Site Status

Clinique du Millenaire Service de Cardiologie Interventionelle

Montpellier, , France

Site Status

Institut Mutualiste Montsouris

Paris, , France

Site Status

Hopital Bichat

Paris, , France

Site Status

CHU de Bordeaux Hopital du Haut Leveque

Pessac, , France

Site Status

CHU de Rouen

Rouen, , France

Site Status

Clinique Saint-Hilaire

Rouen, , France

Site Status

Nouvel Hopital Civil

Strasbourg, , France

Site Status

Clinique Pasteur / GCVI

Toulouse, , France

Site Status

Kerckhoff-Klinik

Bad Nauheim, , Germany

Site Status

Herz und Gefaess Klinik

Bad Neustadt an der Saale, , Germany

Site Status

Segeberger Kliniken

Bad Segeberg, , Germany

Site Status

Charite Universitatsmedizin Berlin

Berlin, , Germany

Site Status

Immanuel Klinikum Bernau Herzzentrum Brandenburg

Berlin, , Germany

Site Status

Gesundheit Nord gGmbH

Bremen, , Germany

Site Status

Klinikum der Stadt Ludwigshafen

Dortmund, , Germany

Site Status

St. Johannes - Hospital

Dortmund, , Germany

Site Status

Heart Center Dresden, University Clinic Technical University Dresden

Dresden, , Germany

Site Status

Universitätsklinikum Düsseldorf

Düsseldorf, , Germany

Site Status

Elisabeth Krankenhaus Essen Klinik fur Kardiologie und Angiologie

Essen, , Germany

Site Status

Klinikum Fulda gAG

Fulda, , Germany

Site Status

Universitatsklinikum Halle (Saale)

Halle, , Germany

Site Status

Asklepios St. Georg Abteilung fuer Kardiologie

Hamburg, , Germany

Site Status

Heidelberg University Hospital

Heidelberg, , Germany

Site Status

Universitaetsklinik Schleswig-Holstein Campus Kiel

Kiel, , Germany

Site Status

MediClin Herzzentrum Lahr/Baden

Lahr, , Germany

Site Status

Herzzentrum Leipzig

Leipzig, , Germany

Site Status

Universitatsmedizin Mainz, Zentrum fur Kardiologie

Mainz, , Germany

Site Status

Deutsches Herzzentrum Munchen

München, , Germany

Site Status

Universitatsklinikum Essen, Klinik fur Kardiologie

München, , Germany

Site Status

Klinikum rechts der Isar der Technischen Universitat Munchen

München, , Germany

Site Status

Klinikum Oldenburg AöR

Oldenburg, , Germany

Site Status

Uniklinikum Regensburg, Med II

Regensburg, , Germany

Site Status

Krankenhaus der Barmherzigen

Trier, , Germany

Site Status

Universitaetsklinikum Tuebingen Medizinische Klinik, Abteilung III

Tübingen, , Germany

Site Status

Universitatsklinikum Ulm

Ulm, , Germany

Site Status

Helios Herzzentrum Wuppertal

Wuppertal, , Germany

Site Status

Universitatsklinikum Wurzburg

Würzburg, , Germany

Site Status

Ospedali Riuniti Torrette Di Ancona

Ancona, , Italy

Site Status

Policlinico Sant'Orsola-Malpighi

Bologna, , Italy

Site Status

ASST Spedali Civili di Brescia-UO Cardiologia

Brescia, , Italy

Site Status

AOU Policlinico Vittorio Emanuele

Catania, , Italy

Site Status

Magna Graecia University

Catanzaro, , Italy

Site Status

Ospedale S. Croce e Carle

Cuneo, , Italy

Site Status

Citta di Lecce Hospital

Lecce, , Italy

Site Status

Azienda Socio Sanitaria Territoriale di Lecco

Lecco, , Italy

Site Status

ASST Ovest Milanese - Presidio Ospedallero di Legnana

Legnano, , Italy

Site Status

Fondazione Toscana Gabriele Monasterio

Massa, , Italy

Site Status

Ospedale San Raffaele

Milan, , Italy

Site Status

Centro Cardiologico Monzino IRCCS

Milan, , Italy

Site Status

ASST Grande Ospedale Metropolitano Niguarda

Milan, , Italy

Site Status

Clinica Mediterranea

Napoli, , Italy

Site Status

A.A Dei Colli Monaldi UOC Cardiologia Interventistica

Napoli, , Italy

Site Status

Azienda Ospedaliera di Padova

Padua, , Italy

Site Status

Fondazione IRCCS Policlinico San Matteo

Pavia, , Italy

Site Status

IRCCS Policlinico San Matteo

Pavia, , Italy

Site Status

Centro Cuore Morgagni

Pedara, , Italy

Site Status

Azienda Ospedaliero-Universitaria Pisana

Pisa, , Italy

Site Status

IRCCS-ASMN Reggio Emilia

Reggio Emilia, , Italy

Site Status

AO San Camillo Forlanini

Rome, , Italy

Site Status

Azienda Ospedaliero-Universitaria Policlinico Umberto I

Rome, , Italy

Site Status

AOU Careggi, Interventistica Cardiologica Strutturale

Rome, , Italy

Site Status

Ospedale Sant'Andrea - U.O.S. Emodinamica Cardiologia Interventistica

Rome, , Italy

Site Status

Istituto Clinico Humanitas

Rozzano, , Italy

Site Status

AOU S.Giovanni Di Dio e Ruggi D'Aragona

Salerno, , Italy

Site Status

IRCCS Policlinico San Donato

San Donato Milanese, , Italy

Site Status

UOC Emodinamica III

Siena, , Italy

Site Status

Azienda Ospedaliera Integrata di Verona

Verona, , Italy

Site Status

Nagoya Heart Center

Toyohashi, Aichi-ken, Japan

Site Status

Kokura Memorial Hospital

Kitakyushu, Fukuoka, Japan

Site Status

Ogaki Municipal Hospital

Ōgaki, Gifu, Japan

Site Status

Sapporo Higashi Tokushukai Hospital

Sapporo, Hokkaido, Japan

Site Status

Tsukuba Medical Center Hospital

Amakubo, Ibaraki, Japan

Site Status

Teikyo University Hospital

Tokyo, Itabashi, Japan

Site Status

Iwate Medical University Hospital

Morioka, Iwate, Japan

Site Status

Tokai University Hospital

Isehara, Kanagawa, Japan

Site Status

St. Marianna University School of Medicine Hospital

Kawasaki, Kanagawa, Japan

Site Status

Saiseikai Yokohamashi Tobu Hospital

Yokohama, Kanagawa, Japan

Site Status

Sendai Kousei Hospital

Sendai, Miyagi, Japan

Site Status

Osaka City University Hospital

Abeno Ward, Osaka, Japan

Site Status

Kishiwada Tokushukai Hospital

Kishiwada, Osaka, Japan

Site Status

Keio University Hospital

Shinjuku, Tokyo, Japan

Site Status

Toyohashi Heart Center

Aichi, , Japan

Site Status

New Tokyo Hospital

Chiba, , Japan

Site Status

Shonan Kamakura General Hospital

Kanagawa, , Japan

Site Status

Toyama University Hospital

Toyama, , Japan

Site Status

Academic Medical Center

Amsterdam, , Netherlands

Site Status

University Medical Center Groningen

Groningen, , Netherlands

Site Status

Medisch Centrum Leeuwarden

Leeuwarden, , Netherlands

Site Status

Erasmus Medical Center

Rotterdam, , Netherlands

Site Status

HagaZiekenhuis

The Hague, , Netherlands

Site Status

Uniwersytecki Szpital Kliniczny w Bialymstoku

Bialystok, , Poland

Site Status

University Clinical Centre in Gdańsk

Gdansk, , Poland

Site Status

Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu

Poznan, , Poland

Site Status

Seoul National University Hospital

Seoul, Jongno-gu, South Korea

Site Status

Seoul St. Mary's Hospital

Seoul, Seocho-gu, South Korea

Site Status

Yonsei University Severance Hospital

Seoul, Seodaemun-gu, South Korea

Site Status

Korean University Anam Hospital

Seoul, Seongbuk-gu, South Korea

Site Status

Asan Medical Center

Seoul, Songpa-gu, South Korea

Site Status

Hospital Universitario Virgen Macarena

Seville, Andalusia, Spain

Site Status

Hospital Universitari Germans Trias I Pujol

Badalona, Barcelona, Spain

Site Status

Hospital Universitario Donostia

Donostia / San Sebastian, Gipuzkoa, Spain

Site Status

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, Spain

Site Status

Complexo Hospitalario Universitario de A Coruna

A Coruña, , Spain

Site Status

Complexo hospitalario universitario de Santiago de Compostela

A Coruña, , Spain

Site Status

Hospital General Universitario de Alicante

Alicante, , Spain

Site Status

Hospital Universitario Vall d'Hebron

Barcelona, , Spain

Site Status

Hospital Clinico y Provincial de Barcelona

Barcelona, , Spain

Site Status

Complejo Asistencial de Granada

Granada, , Spain

Site Status

Hospital La Luz QuironSalud

Madrid, , Spain

Site Status

Hospital Universitario La Princesa

Madrid, , Spain

Site Status

Hospital Universitario Ramón y Cajal

Madrid, , Spain

Site Status

Hospital Clinico San Carlos

Madrid, , Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Hospital Universitario Virgen de la Victoria

Málaga, , Spain

Site Status

Hospital Virgen de la Arrixaca

Murcia, , Spain

Site Status

Valdecilla Hospital

Santander, , Spain

Site Status

Hospital Universitario Virgen del Rocio

Seville, , Spain

Site Status

Hospital Clinico de Valencia

Valencia, , Spain

Site Status

Hospital Clinico Universitario de Valladolid

Valladolid, , Spain

Site Status

Hospital Universitario Alvaro Cunqueiro

Vigo, , Spain

Site Status

Universitatsspital Basel

Basel, , Switzerland

Site Status

Bern University Hospital

Bern, , Switzerland

Site Status

Hopitaux Universitaires de Geneve

Geneva, , Switzerland

Site Status

Cardiocentro Ticino

Lugano, , Switzerland

Site Status

BSUH, Cardiac Research Unit

Brighton, England, United Kingdom

Site Status

Papworth Hospital NHS Foundation Trust

Cambridge, England, United Kingdom

Site Status

Royal Edinburgh Infirmary

Edinburgh, England, United Kingdom

Site Status

Guys St Thomas Hospital

London, England, United Kingdom

Site Status

Trent Cardiac Centre

Nottingham, England, United Kingdom

Site Status

Oxford University Hospitals, John Radcliffe Hospital

Oxford, England, United Kingdom

Site Status

Northern General Hospital

Sheffield, England, United Kingdom

Site Status

University Hospital of Wales, Heath Park

Cardiff, Wales, United Kingdom

Site Status

University Hospitals of Leicester NHS Trust

Leicester, , United Kingdom

Site Status

Derriford Hospital

Plymouth, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Austria Belgium Canada France Germany Italy Japan Netherlands Poland South Korea Spain Switzerland United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Dangas GD, Unverdorben M, Nicolas J, Hengstenberg C, Chen C, Mollmann H, Jin J, Shawl F, Yamamoto M, Saito S, Hambrecht R, Duggal A, Van Mieghem NM. Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE-TAVI AF Trial. J Am Heart Assoc. 2025 May 20;14(10):e033321. doi: 10.1161/JAHA.123.033321. Epub 2025 May 15.

Reference Type DERIVED
PMID: 40371611 (View on PubMed)

Van Mieghem NM, Unverdorben M, Hengstenberg C, Mollmann H, Mehran R, Lopez-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodes-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28.

Reference Type DERIVED
PMID: 34449183 (View on PubMed)

Giacoppo D. Anticoagulation After Transcatheter Aortic Valve Replacement: Evolving Answers and Still Unaddressed Questions. JACC Cardiovasc Interv. 2021 Aug 9;14(15):1714-1716. doi: 10.1016/j.jcin.2021.06.004. Epub 2021 Jul 14. No abstract available.

Reference Type DERIVED
PMID: 34274293 (View on PubMed)

Van Mieghem NM, Unverdorben M, Valgimigli M, Mehran R, Boersma E, Baber U, Hengstenberg C, Shi M, Chen C, Saito S, Veltkamp R, Vranckx P, Dangas GD. Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. Am Heart J. 2018 Nov;205:63-69. doi: 10.1016/j.ahj.2018.07.006. Epub 2018 Aug 29.

Reference Type DERIVED
PMID: 30172099 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-003930-26

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

DU176B-C-U4001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.